| |
| |
|
| Insider
Information: |
Oday Daniel Patrick |
| Relationship: |
Chairman & CEO, Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
484,847 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$32,489,597 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
484,847 |
|
|
| Total
Value |
$32,489,597 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chairman & CEO, Director |
2024-03-10 |
484,847 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2022-09-10 |
4 |
D |
$65.28 |
$99,748 |
D/D |
(1,528) |
252,878 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2022-06-10 |
4 |
D |
$60.74 |
$93,479 |
D/D |
(1,539) |
251,105 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2022-12-10 |
4 |
D |
$87.97 |
$135,650 |
D/D |
(1,542) |
254,636 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2022-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,300 |
252,644 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2022-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,300 |
256,178 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2022-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,301 |
254,406 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2023-12-10 |
4 |
D |
$79.02 |
$264,006 |
D/D |
(3,341) |
387,691 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2023-09-10 |
4 |
D |
$76.00 |
$255,816 |
D/D |
(3,366) |
383,685 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2023-06-10 |
4 |
D |
$78.12 |
$266,311 |
D/D |
(3,409) |
266,125 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2023-03-01 |
4 |
D |
$79.59 |
$385,375 |
D/D |
(4,842) |
359,495 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2021-03-10 |
4 |
D |
$63.91 |
$327,411 |
D/D |
(5,123) |
142,013 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,346 |
269,534 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2023-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,347 |
391,032 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2023-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,348 |
387,051 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,800 |
147,136 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2022-03-10 |
4 |
D |
$57.92 |
$640,132 |
D/D |
(11,052) |
249,344 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2023-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,362 |
364,337 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2024-03-10 |
4 |
D |
$75.12 |
$1,035,304 |
D/D |
(13,782) |
484,847 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2023-03-10 |
4 |
D |
$79.50 |
$1,114,352 |
D/D |
(14,017) |
375,766 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
19,204 |
19,204 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2022-03-01 |
4 |
D |
$60.26 |
$1,400,744 |
D/D |
(23,245) |
236,393 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2022-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,003 |
260,396 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2021-03-01 |
4 |
D |
$62.46 |
$1,537,765 |
D/D |
(24,620) |
136,336 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2020-03-01 |
4 |
D |
$69.36 |
$1,797,950 |
D/D |
(25,922) |
47,570 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman & CEO |
• • – |
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,940 |
498,629 |
0 |
- |
|
36 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
